Finland also paused the use of Moderna's COVID-19 vaccine for younger males
Finland on Thursday paused the use of Moderna's (MRNA.O) COVID-19 vaccine for younger males due to reports of a rare cardiovascular side effect, joining Sweden and Denmark in limiting its use, Reuters reports.
Mika Salminen, director of the Finnish health institute, said Finland would instead give Pfizer's vaccine to men born in 1991 and later. Finland offers shots to people aged 12 and over.
"A Nordic study involving Finland, Sweden, Norway and Denmark found that men under the age of 30 who received Moderna Spikevax had a slightly higher risk than others of developing myocarditis," he said.
Swedish and Danish health officials had announced on Wednesday they would pause the use of the Moderna vaccine for all young adults and children, citing the same unpublished study.
Esta publicación es para usuarios registrados
Please register or log in with your account to read the full publication.